M3 Global Research, part of M3 Inc., provides market research recruitment, data collection, and support services reaching respondents in 248 markets across 70 countries worldwide with a strong emphasis on the healthcare space. Working in highly regulated industries, M3 maintains ISO 20252 and 27001 certifications, providing data collection and project management capabilities covering a broad spectrum of quantitative and qualitative techniques.
M3 Global Research helps people in the healthcare industry access the expert opinions of doctors and a variety of other professionals regarding products and services currently or potentially being marketed. These may include new or expanded prescription medications, medical equipment, insurance-related issues or different treatment options for specific diseases, among many others. It is critically important for anyone introducing new innovations in this complicated and competitive space to conduct the most thorough research possible to insure their products are relevant, safe, and will have an opportunity to succeed in the marketplace. M3 is the recognized worldwide leader at doing just that.
The M3 Group operates in the US, Asia, and Europe with over 4 million physician members globally via its physician websites including: m3.com, mdlinx.com, Doctors.net.uk, thesmartestdoc.com, medigate.net, medlive.cn.
M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul.